Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S R Dillon

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Leukemia|November 30, 2007
Atacicept (TACI-Ig) inhibits growth of TACI(high) primary myeloma cells in SCID-hu mice and in coculture with osteoclastsS Yaccoby, A Pennisi, X Li, et al.
Autoimmunity|March 21, 2009
The receptor tyrosine kinase MerTK regulates dendritic cell production of BAFFP R Gohlke, J C Williams, B J Vilen, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|November 29, 2008
TACI-Ig prevents the development of airway hyperresponsiveness in a murine model of asthmaJ Bilsborough, E Chadwick, S Mudri, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 9, 2016
Interleukin (IL) 31 induces in cynomolgus monkeys a rapid and intense itch response that can be inhibited by an IL-31 neutralizing antibodyK E Lewis, M S Holdren, M F Maurer, et al.
Immunity|August 25, 2001
TACI-Ig neutralizes molecules critical for B cell development and autoimmune disease. impaired B cell maturation in mice lacking BLySJ A Gross, S R Dillon, S Mudri, et al.
Nature|May 9, 2000
TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune diseaseJ A Gross, J Johnston, S Mudri, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 2, 2001
A soluble class II cytokine receptor, IL-22RA2, is a naturally occurring IL-22 antagonistW Xu, S R Presnell, J Parrish-Novak, et al.
Nature|November 18, 2000
Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte functionJ Parrish-Novak, S R Dillon, A Nelson, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Leukemia|November 30, 2007
Atacicept (TACI-Ig) inhibits growth of TACI(high) primary myeloma cells in SCID-hu mice and in coculture with osteoclastsS Yaccoby, A Pennisi, X Li, et al.
Autoimmunity|March 21, 2009
The receptor tyrosine kinase MerTK regulates dendritic cell production of BAFFP R Gohlke, J C Williams, B J Vilen, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|November 29, 2008
TACI-Ig prevents the development of airway hyperresponsiveness in a murine model of asthmaJ Bilsborough, E Chadwick, S Mudri, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 9, 2016
Interleukin (IL) 31 induces in cynomolgus monkeys a rapid and intense itch response that can be inhibited by an IL-31 neutralizing antibodyK E Lewis, M S Holdren, M F Maurer, et al.
Immunity|August 25, 2001
TACI-Ig neutralizes molecules critical for B cell development and autoimmune disease. impaired B cell maturation in mice lacking BLySJ A Gross, S R Dillon, S Mudri, et al.
Nature|May 9, 2000
TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune diseaseJ A Gross, J Johnston, S Mudri, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 2, 2001
A soluble class II cytokine receptor, IL-22RA2, is a naturally occurring IL-22 antagonistW Xu, S R Presnell, J Parrish-Novak, et al.
Nature|November 18, 2000
Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte functionJ Parrish-Novak, S R Dillon, A Nelson, et al.
Pageof 2